Beactica scientists describe strategies for fragment-based drug discovery in two publications in Journal of Medicinal Chemistry. The research is a result of an international collaboration between Beactica, IOTA Pharmaceuticals Ltd, Cambridge, UK, and scientists at Uppsala University, Sweden.
Uppsala, Sweden, 4 February 2011 >Read more

For the general public

All over the world, scientists are trying hard to determine the three dimensional structure of membrane proteins as a key process for pharmacological research. Neurocypres is a program selected within the first call from the EU’s 7th Research Framework Programme. Read more >


Neurocypres is a large-scale integrated project involving 20 European laboratories in the area of Cys-loop neurotransmitter receptors funded by the European Union as of February 1, 2008. The EU commission devoted a special call to stimulate high-throughput approaches to structure function analyses of membrane-transporters and channels for the identification of potential new drug target sites. The Neurocypres consortium is devoted to studying structural and functional aspects of Cys-loop receptors, a superfamily of ligand-gated ion channels. Read more >


More information about the progress state of the Neurocypres Project. Read more >


The third annual meeting was held on May 27, 28 and 29 in Bergamo, Italy. Read more >

© 2018 | Contact us